Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Subscribe to see Axe Compute Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Axe Compute Inc. is an ai/ml company headquartered in Pittsburgh, United States. It is publicly listed (AGPU) with a market capitalisation of $122.1M. Xcout tracks 17 named people at Axe Compute Inc., including Christopher Miglino (Chief Executive Officer & Director).
11 more named people on record for Axe Compute Inc., with roles, board committees and tenure — see the full roster →
A few of Axe Compute Inc.'s closest competitors — see the full list of competitors and alternatives →
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Digital Ether Computing develops adaptive artificial intelligence architectures across two primary divisions focused on life sciences and high-stakes operations. Its Discovery division provides AI-driven platforms for drug discovery, structural biology, and functional genomics, while its Systems division builds deployable, mission-grade intelligence for defense, aerospace, and commercial sectors.
Synagen AI is a bootstrapped healthcare technology company headquartered in Dresden, Germany, focused on developing pioneering AI-driven agents for oncology and medical advancements.
Tensor Black, Inc. operates a digital platform tailored for oncology professionals. The company provides artificial intelligence insights, expert knowledge, news, educational courses, and community networking to support cancer care.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.